摘要 |
The subject invention provides ginkgolide C derivatives compounds having the structure: wherein R is H or -A-Ar, where A is an alkyl group; and Ar is an aryl group, which may contain heteroatoms and may be unsubstituted or substituted by one to five substituents each selected from the group consisting of hydrogen, alkoxy, -CH<SUB>2</SUB>CO<SUB>2</SUB>R<SUP>4</SUP>, and -CH<SUB>2</SUB>CONR<SUP>5</SUP>R<SUP>6</SUP>; where R<SUP>4 </SUP>is an alkyl group; and R<SUP>5 </SUP>and R<SUP>6 </SUP>are each, independently, hydrogen or a branched or unbranched alkyl group; wherein R<SUP>1 </SUP>is H or -COR<SUP>7</SUP>, where R<SUP>7 </SUP>is alkyl, aryl or amino; wherein R<SUP>2 </SUP>is present or absent, and when present is H, -COR<SUP>8 </SUP>or -CO-Z-R<SUP>8</SUP>; where R<SUP>8 </SUP>is alkyl, aryl or amino; and Z is oxygen; wherein R<SUP>3 </SUP>is present or absent, and when present is -COR<SUP>9</SUP>; where R<SUP>9 </SUP>is alkyl or aryl; wherein only one of R<SUP>2 </SUP>or R<SUP>3 </SUP>is present in the compound; wherein only two of R, R<SUP>1</SUP>, R<SUP>2 </SUP>and R<SUP>3 </SUP>are H; and wherein each of a and b designates a single covalent bond which is present or absent, where bond a is present when R<SUP>3 </SUP>is absent and bond b is present when R<SUP>2 </SUP>is absent; or an optically pure enantiomer of the compound. Additionally, the subject invention provides methods of inhibiting the activity of a glycine receptor using these compounds. |